Association between liver targeted antiviral therapy in colorectal cancer and survival benefits:An appraisal  

作　　者：Qiang Wang Chao-Ran Yu 

机构地区：[1]Fudan University Shanghai Cancer Center,Department of Oncology,Shanghai Medical College,Shanghai 200025,China

出　　处：《World Journal of Clinical Cases》2020年第11期2111-2115,共5页世界临床病例杂志

摘　　要：In colorectal cancer(CRC),liver metastasis remains a major contributor to the cause of cancer-related death.Putative biomarkers,therapeutic efficacy,and drug insensitivity still pose clinical challenges for metastatic CRC patients.Interestingly,previous studies indicated that tumor cells in CRC did not metastasize to the injured liver,which included hepatitis or cirrhotic liver.The benefits of antiviral therapy on hepatocellular carcinoma have also been identified.This review discusses the role of antiviral therapy on the liver.Antiviral therapy may reduce potential liver metastasis associated with CRC in several mechanistic aspects.

关 键 词：Colorectal cancer Liver metastasis Antiviral therapy SURVIVAL Injury status Biomarkers 

分 类 号：R735.34[医药卫生—肿瘤]